The Free Market Eventually Triumphs

Today’s Daily Caller posted a story about a change in the research and use of stem cells.

The article reported:

Geron Corp., the world’s leading embryo research company, announced it was closing down its much-touted stem cell program, despite the guarantee of more government aid from Democratic-affiliated sources.

The article explained that most stem cells used in hospitals and medical facilities today are adult stem cells taken from the patient’s own body.

The article concludes:

Those “adult stem cells” can be stimulated to regenerate damaged hearts and other organs. In one peer reviewed study published on Nov. 16, more than a dozen heart-failure patients gained an average 12 percent improvement in heart function from their own stimulated stem cells.

This uncontroversial adult cell technology was pioneered by hospitals, not drug companies. It is sufficiently reliable that insurance companies green-light its use for the treatment of multiple sclerosis, lupus and many other ailments, and it is cheered by social conservatives and religious groups because it improves medical treatments without killing human embryos.

When a technology works well, it will be used more, without having to rely on the government to pay for it.

Enhanced by Zemanta